Evaxion Biotech A/S EVAX Stock
Evaxion Biotech A/S Price Chart
Evaxion Biotech A/S EVAX Financial and Trading Overview
| Evaxion Biotech A/S stock price | 4.1 USD |
| Previous Close | 1.3 USD |
| Open | 1.33 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.28 - 1.35 USD |
| 52 Week Range | 0.92 - 3.52 USD |
| Volume | 89.59K USD |
| Avg. Volume | 247.21K USD |
| Market Cap | 34.11M USD |
| Beta (5Y Monthly) | 0.568862 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.1 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.67 USD |
EVAX Valuation Measures
| Enterprise Value | 28.45M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.65816325 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.7499998 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.145 |
Trading Information
Evaxion Biotech A/S Stock Price History
| Beta (5Y Monthly) | 0.568862 |
| 52-Week Change | -19.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.52 USD |
| 52 Week Low | 0.92 USD |
| 50-Day Moving Average | 1.43 USD |
| 200-Day Moving Average | 1.82 USD |
EVAX Share Statistics
| Avg. Volume (3 month) | 247.21K USD |
| Avg. Daily Volume (10-Days) | 1.09M USD |
| Shares Outstanding | 26.44M |
| Float | 16.34M |
| Short Ratio | 4.26 |
| % Held by Insiders | 42.47% |
| % Held by Institutions | 0.40% |
| Shares Short | 254.31K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -24854000 USD |
| Net Income Avi to Common (ttm) | -23619000 USD |
| Diluted EPS (ttm) | -0.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.18M USD |
| Total Cash Per Share (mrq) | 0.55 USD |
| Total Debt (mrq) | 10.26M USD |
| Total Debt/Equity (mrq) | 123.51 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.344 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Evaxion Biotech A/S
| Country | United States |
| State | N/A |
| City | Horsholm |
| Address | Dr. Neergaards Vej |
| ZIP | 2970 |
| Phone | 45 53 53 18 50 |
| Website | https://www.evaxion-biotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 63 |
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Q&A For Evaxion Biotech A/S Stock
What is a current EVAX stock price?
Evaxion Biotech A/S EVAX stock price today per share is 4.1 USD.
How to purchase Evaxion Biotech A/S stock?
You can buy EVAX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evaxion Biotech A/S?
The stock symbol or ticker of Evaxion Biotech A/S is EVAX.
Which industry does the Evaxion Biotech A/S company belong to?
The Evaxion Biotech A/S industry is Biotechnology.
How many shares does Evaxion Biotech A/S have in circulation?
The max supply of Evaxion Biotech A/S shares is 5.22M.
What is Evaxion Biotech A/S Price to Earnings Ratio (PE Ratio)?
Evaxion Biotech A/S PE Ratio is now.
What was Evaxion Biotech A/S earnings per share over the trailing 12 months (TTM)?
Evaxion Biotech A/S EPS is -8.1 USD over the trailing 12 months.
Which sector does the Evaxion Biotech A/S company belong to?
The Evaxion Biotech A/S sector is Healthcare.
Evaxion Biotech A/S EVAX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}